DON treatment also significantly impaired the metastasis activity of thyroid cancer cells, not likely from EMT reversal, as epithelial and mesenchymal markers, including E-cadherin, N-cadherin, and Vimentin, were all decreased upon DON or JHU-083 treatment in vitro or in vivo. The gene discussed is CDH2; the disease is thyroid cancer.